Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
METRO-ABC: SAR439281 in Metastatic Breast Cancer
NCT02664103Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jan 2016
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Comcapsy in breast cancer, sponsored by Sanofi. Started Jan 2016; status: completed.
02
Drugs
Comcapsy
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02664103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02664103.